Difference between revisions of "Safety-enhanced design (MU3))"
From OpenEMR Project Wiki
Bradymiller (talk | contribs) |
Bradymiller (talk | contribs) |
||
| Line 21: | Line 21: | ||
==Task 2: Enter in medication order.== | ==Task 2: Enter in medication order.== | ||
:*Order Lipitor, which will throw a allergy interaction warning. | :*Order Lipitor (via prescription), which will throw a allergy interaction warning. | ||
:*(a1: Computerized provider order entry (CPOE) – medications) | :*(a1: Computerized provider order entry (CPOE) – medications) | ||
:*(a9: Clinical decision support) | :*(a9: Clinical decision support) | ||
Revision as of 08:13, 17 January 2022
Overview
- Working with Columbia HIT
Research
- Example reports:
Usability demos
- Plan 3 duplicate demos that will contain 1 patient (Ed Smith with a Lipitor allergy) with one lab option (PSA). Demos can be easily reset after the test is complete.
Usability testing instruction sets
Task 1: Enter and modify demographics.
- Enter in Gender Identity and Sexual Orientation
- Change DOB
- (a5: Demographics)
- (if allergy a9 cdr does not work out below, then can have the dob change trigger the colonoscopy cdr message)
Task 2: Enter in medication order.
- Order Lipitor (via prescription), which will throw a allergy interaction warning.
- (a1: Computerized provider order entry (CPOE) – medications)
- (a9: Clinical decision support)
Task 3: Order a lab.
- Order PSA
- (a2: CPOE – laboratory)
Task 4: Add a implantable device.
- Add UDI (01)10050428383077(11)141231(17)150707(10)A213B1(21)1234
- (a14: Implantable device list)
